Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Solasia Pharma KK (DE:9SO)
FRANKFURT:9SO
Holding DE:9SO?
Track your performance easily
9SO Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.13 - €0.42
Previous Close€0.25
Volume0.00
Average Volume (3M)5.01K
Market Cap
€59.30M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.34
Next Earnings
Feb 12, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume5,011
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)6.27
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Solasia Pharma KK News
PremiumCompany Announcements
Solasia Pharma Nears DARVIAS Licensing Deal in China
PremiumCompany Announcements
Solasia Pharma K.K. Faces Revenue Decline9SO FAQ
What was Solasia Pharma KK’s price range in the past 12 months?
Solasia Pharma KK lowest stock price was €0.13 and its highest was €0.42 in the past 12 months.
What is Solasia Pharma KK’s market cap?
Currently, no data Available
When is Solasia Pharma KK’s upcoming earnings report date?
Solasia Pharma KK’s upcoming earnings report date is Feb 12, 2025 which is in 81 days.
How were Solasia Pharma KK’s earnings last quarter?
Solasia Pharma KK released its earnings results on Nov 13, 2024. The company reported -€0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.007.
Is Solasia Pharma KK overvalued?
According to Wall Street analysts Solasia Pharma KK’s price is currently Overvalued.
Does Solasia Pharma KK pay dividends?
Solasia Pharma KK does not currently pay dividends.
What is Solasia Pharma KK’s EPS estimate?
Solasia Pharma KK’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Solasia Pharma KK have?
Solasia Pharma KK has 218,358,920 shares outstanding.
What happened to Solasia Pharma KK’s price movement after its last earnings report?
Solasia Pharma KK reported an EPS of -€0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.846%.
Which hedge fund is a major shareholder of Solasia Pharma KK?
Currently, no hedge funds are holding shares in DE:9SO
---
Solasia Pharma KK Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
-57.51%
Trailing 12-Months
Asset Growth
3.18%
Trailing 12-Months
Company Description
Solasia Pharma KK
Solasia Pharma KK develops and distributes pharmaceuticals and medical devices relating to malignant tumors.
---
Technical Analysis
---